Goldman Sachs Defends Intuitive Surgical (ISRG)

March 18, 2013 10:45 AM EDT Send to a Friend
Get Alerts ISRG Hot Sheet
Price: $478.01 -1.55%

Rating Summary:
    22 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade ISRG Now!
Join SI Premium – FREE
Goldman Sachs today maintained a Buy rating on Intuitive Surgical (NASDAQ: ISRG) with a price target of $715.00. Analysts said further downside in the stock was limited, even under an extreme bear case.

"By our math, we see fundamental risk in the 9% range, assuming that hysterectomy procedures flatten out in 2013 (vs. GSe at +22%) and growth in new procedures is cut in half (from 38% to 19%)," said analyst David H. Roman.

"Initial channel feedback refutes the prospects for either of these outcomes. Moreover, we have learned that a growing contingent of surgeons is taking a public stand to promote robotic surgery benefits for practitioners, patients, and health systems," added the analyst.

Shares of Intuitive Surgical are down 20 percent in the past month.

For an analyst ratings summary and ratings history on Intuitive Surgical (NASDAQ: ISRG) click here. For more ratings news on Intuitive Surgical click here.

Shares of Intuitive Surgical closed at $459.44 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Trader Talk

Related Entities

Goldman Sachs

Add Your Comment